Invesaro

Stocks Comparison

Cryo Cell International vs Sotera Health: revenue, profit, margins and growth compared

Cryo Cell International brought in $31.6M of revenue in fiscal 2025, Sotera Health $1.2B in fiscal 2025. Revenue changed by -1.3% at Cryo Cell International and +5.7% at Sotera Health on the year before, so Sotera Health grew faster. Cryo Cell International kept -7.7% of its revenue as net profit, Sotera Health 6.7%. Free cash flow was $5.2M at Cryo Cell International and $149.2M at Sotera Health.

Side by side, latest fiscal year

CCELSHC
Fiscal year endedFY2025 (November 30, 2025)FY2025 (December 31, 2025)
Revenue$31.6M$1.2B
Revenue growth-1.3%+5.7%
Net income-$2.4M$77.9M
Net margin-7.7%6.7%
Free cash flow$5.2M$149.2M
Free cash flow margin16.6%12.8%
Earnings per share (diluted)-$0.30$0.27
Cash$319K$344.6M
Debt$8.4M$2.1B
Price to earningsn/a67.9
Market value$34.2M$5.2B
Dividend yieldn/an/a
Rank by revenue in sector#412 of 646 · Health care#139 of 646 · Health care

Over the years

Revenue
CCEL FY2018: $29.2MCCEL FY2019: $31.8MCCEL FY2020: $31.1MCCEL FY2021: $28.9MCCEL FY2022: $30.3MCCEL FY2023: $31.3MCCEL FY2024: $32MCCEL FY2025: $31.6MSHC FY2019: $778.3MSHC FY2021: $818.2MSHC FY2021: $931.5MSHC FY2022: $1BSHC FY2023: $1BSHC FY2024: $1.1BSHC FY2025: $1.2BFY18FY19FY20FY21FY22FY23FY24FY25
CCEL $31.6MSHC $1.2B
Net income
CCEL FY2018: -$854.8KCCEL FY2019: $2.3MCCEL FY2020: $3.6MCCEL FY2021: $2.1MCCEL FY2022: $2.8MCCEL FY2023: -$9.5MCCEL FY2024: $402.1KCCEL FY2025: -$2.4MSHC FY2019: -$20.9MSHC FY2021: -$38.6MSHC FY2021: $116.9MSHC FY2022: -$233.6MSHC FY2023: $51.4MSHC FY2024: $44.4MSHC FY2025: $77.9MFY18FY19FY20FY21FY22FY23FY24FY25
CCEL -$2.4MSHC $77.9M
Net margin
CCEL FY2018: -2.9%CCEL FY2019: 7.2%CCEL FY2020: 11.6%CCEL FY2021: 7.2%CCEL FY2022: 9.1%CCEL FY2023: -30.4%CCEL FY2024: 1.3%CCEL FY2025: -7.7%SHC FY2019: -2.7%SHC FY2021: -4.7%SHC FY2021: 12.5%SHC FY2022: -23.3%SHC FY2023: 4.9%SHC FY2024: 4.0%SHC FY2025: 6.7%FY18FY19FY20FY21FY22FY23FY24FY25
CCEL -7.7%SHC 6.7%
Revenue growth
CCEL FY2019: +8.9%CCEL FY2020: -2.1%CCEL FY2021: -7.3%CCEL FY2022: +5.0%CCEL FY2023: +3.3%CCEL FY2024: +2.0%CCEL FY2025: -1.3%SHC FY2021: +5.1%SHC FY2021: +13.9%SHC FY2022: +7.8%SHC FY2023: +4.5%SHC FY2024: +4.9%SHC FY2025: +5.7%FY19FY20FY21FY22FY23FY24FY25
CCEL -1.3%SHC +5.7%
Free cash flow
CCEL FY2018: $4.9MCCEL FY2019: $5.6MCCEL FY2020: $8.4MCCEL FY2021: $6.1MCCEL FY2022: -$3.6MCCEL FY2023: $2.1MCCEL FY2024: $3.6MCCEL FY2025: $5.2MSHC FY2019: $91.8MSHC FY2021: $67.1MSHC FY2021: $179.4MSHC FY2022: $95.6MSHC FY2023: -$362.7MSHC FY2024: $45.1MSHC FY2025: $149.2MFY18FY19FY20FY21FY22FY23FY24FY25
CCEL $5.2MSHC $149.2M

Fiscal years as each company reports them; the two may end in different months.

Questions about Cryo Cell International and Sotera Health

Which is bigger by revenue, Cryo Cell International or Sotera Health?

Sotera Health is bigger by revenue: $1.2B in fiscal 2025, against $31.6M for Cryo Cell International in fiscal 2025.

Which keeps more of its revenue as profit, Cryo Cell International or Sotera Health?

Cryo Cell International had a net margin of -7.7% in fiscal 2025; Sotera Health had 6.7% in fiscal 2025.

Which grew revenue faster, Cryo Cell International or Sotera Health?

In their latest fiscal years revenue changed by -1.3% at Cryo Cell International and +5.7% at Sotera Health.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies